Navigation Links
Growers Choose the Bayer CropScience LibertyLinkSystem for Yield and Performance
Date:12/5/2012

/>Bayer CropScience
Tel: (919) 549-2287
Email: arlene(dot)cotie(at)bayer(dot)com

Jayma Appleby
Rhea + Kaiser
Tel: (630) 955-2508
Email: jappleby(at)rkconnect(dot)com

USA-BCS-2012-0500
CR1112LBLINKA072V00R0
Find more information at http://www.bayercropscience.us.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10206932.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. New England Cord Blood Bank chooses Sepax 2 from Biosafe as their Cord Blood Processing Platform
2. Choose New Jersey, Inc. to Tout New Jerseys Life Sciences Hub At Worlds Largest Biotechnology Event
3. Bayer Bee Care Center Helps Solve Bee Health’s Toughest Challenges
4. Bayer CropScience Announces LibertyLink LinkUp Offer Increased for 2013 Season
5. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
6. Bayer Advanced(TM) Sets Sights on New Partnerships in 2013
7. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
8. First Plant Genomics Yield Technology Progresses
9. iDiverse Discovers Yeast Gene that Increases Fuel Ethanol Production Yield
10. Bioreactor redesign dramatically improves yield
11. New method yields insulin-producing pancreatic cell clusters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Clinverse, Inc. , a global ... announced today it has formed a strategic alliance ... FLS eClinical commerce platform aggregates data collected through ... ™, Aggregate Spend Solutions’ recently-launched flagship product, is ... transfer of value at investigator meetings or any ...
(Date:5/21/2013)... 21, 2013 As the R&D ... push within the industry to deliver better products, ... and pharma companies often means turning big ideas ... developed in collaboration with Sensidose AB and Recipharm, ... bring products to market sooner. The partnership resulted ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Bed bugs have ... to My Cleaning Products, many turn to chemical-based pesticides for ... the health and environmental risks those solutions present, the company ... Bed Bug Bully instead. , According to My Cleaning ... as they used to be. It shared that the pests ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3
... - Probing the last genomic frontier of higher organisms, an ... understood - but critical - genetic domain in rice. , ... professor of horticulture at the University of Wisconsin-Madison , ... Research in Rockville, Md., has exposed a supposedly barren ...
... Wis. - Chippewa Valley Technical College (CVTC) ... that CVTC will begin teaching nanotechnology as early as ... sweeping changes and opportunities. , ,Jack Uldrich, nanotechnology author, ... described a shift of historic proportions brought on by ...
... , a Wisconsin-based developer of e-Catalog business solutions ... distribution networks, announced it has expanded its software ... , a manufacturer of products for the lawn ... Cub Cadet, Troy-Bilt, Yard-Man, Ryobi, Yard Machines, McCulloch ...
Cached Biology Technology:Rice Centromere, Supposedly Quiet Genetic Domain, Surprises 2Rice Centromere, Supposedly Quiet Genetic Domain, Surprises 3Chippewa Valley Embraces Nanotechnology 2ARI Links e-Catalog Deal with Outdoor Power Equipment Manufacturer 2
(Date:5/20/2013)... are also commonly resistant to antimicrobial substances made ... in mBio , the online open-access journal ... colistin and host antimicrobials LL-37 and lysozyme, which ... mean that patients with life-threatening multi-drug resistant infections ... Colistin is a last-line drug for treating several ...
(Date:5/20/2013)... ITHACA, N.Y. Little is known about the effect ... new study from Cornell University finds that increasing the ... class reduces the probability of obesity. , The study ... effect of PE on youth obesity, and is forthcoming ... An early, online version of the study can be ...
(Date:5/20/2013)... COLUMBUS, Ohio New research suggests that a compound ... "superpower" to escape death. , By altering a ... re-educates cancer cells into normal cells that die as ... by inhibiting a process that would cause them to ... strict programming. This study in cells, led by Ohio ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3Gym class reduces probability of obesity, study finds for first time 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
... The Food and Drug Administration (FDA) today issued a ... and patient caregivers to new safety information concerning an ... antipsychotic drugs." These drugs are approved for the treatment ... drugs to treat behavioral disorders in elderly patients with ...
... mammalian behavior, physiology, and biochemistry are controlled by the ... suprachiasmatic nucleus (SCN). The clock is synchronized to environmental ... from everyday experience, that adjusting to new light schedules ... adaptation takes place are not well understood. Researchers now ...
... results from a large, randomized clinical trial for ... cancer ?cancer that has spread from the breast ... those patients who received bevacizumab (Avastin? in combination ... before their cancer progressed than patients who received ...
Cached Biology News:FDA Warns About Antipsychotic Drugs and Elderly 2After a time-shift, mixed signals from the circadian clock 2Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer 2Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer 3
IMAGEQUANT 300 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
ANTI MYCOBACTERIUM TUBERCULOSIS...
IMAGEQUANT 100 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
IMAGEQUANT 300 IQTL, 1 EA. Category: ImageQuant CCD Imagers....
Biology Products: